{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:31:06Z","timestamp":1775241066824,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090605","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T16:47:55Z","timestamp":1394729275000},"page":"e90605","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Peadar S.","family":"Waters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roisin M.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Brougham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire L.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Duignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Newell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"E Huntzinger","year":"2011","journal-title":"Nat Rev Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3892\/ijo.2012.1647","article-title":"Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review)","volume":"41","author":"A Allegra","year":"2012","journal-title":"Int J Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/ijc.27642","article-title":"Systemic mirnas as potential biomarkers for malignancy","volume":"131","author":"NA Healy","year":"2012","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"T Sorlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2257","article-title":"MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer","volume":"11","author":"AJ Lowery","year":"2009","journal-title":"Breast Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/gb-2007-8-10-r214","article-title":"MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype","volume":"8","author":"C Blenkiron","year":"2007","journal-title":"Genome Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr3415","article-title":"miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs","volume":"15","author":"M Riaz","year":"2013","journal-title":"Breast Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","article-title":"Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography","volume":"138","author":"PA Carney","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/GRF.0b013e31825ca884","article-title":"Breast cancer screening: clinical, radiologic, and biochemical","volume":"55","author":"ED Feldman","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1745-7599.2010.00564.x","article-title":"Breast cancer screening in women: An integrative literature review","volume":"22","author":"PK Ravert","year":"2010","journal-title":"J Am Acad Nurse Pract"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"b3527","DOI":"10.1136\/bmj.b3527","article-title":"Serum tumour markers: how to order and interpret them","volume":"339","author":"CM Sturgeon","year":"2009","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","article-title":"American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer","volume":"25","author":"L Harris","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"100","author":"LM McShane","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Waters PS, McDermott AM, Wall D, Heneghan HM, Miller N, et al. (2012 ) Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PloS One 7 e50459.","DOI":"10.1371\/journal.pone.0050459"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer","volume":"251","journal-title":"Ann Surg"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2199-9-76","article-title":"Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer","volume":"9","author":"PA Davoren","year":"2008","journal-title":"BMC Mol Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e52979","DOI":"10.1371\/journal.pone.0052979","article-title":"MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity","volume":"7","author":"YC Lee","year":"2012","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2009.05.030","article-title":"MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines","volume":"286","author":"X Liu","year":"2009","journal-title":"Cancer Lett"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1349-7006.2007.00666.x","article-title":"Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines","volume":"99","author":"S Mitomo","year":"2008","journal-title":"Cancer Sci"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R (2013) MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis.","DOI":"10.1093\/carcin\/bgt107"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"E1915","DOI":"10.1210\/jc.2011-0408","article-title":"miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting","volume":"96","author":"M Colamaio","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/bcr3127","article-title":"Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers","volume":"14","author":"E van Schooneveld","year":"2012","journal-title":"Breast Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1016\/j.febslet.2013.06.058","article-title":"MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3","volume":"587","author":"Y Zhang","year":"2013","journal-title":"FEBS Lett"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/carcin\/bgs030","article-title":"Serum microRNA profiling and breast cancer risk: the use of miR-484\/191 as endogenous controls","volume":"33","author":"Z Hu","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"N Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1158\/0008-5472.CAN-10-1313","article-title":"hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy","volume":"70","author":"E Elyakim","year":"2010","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1743-7563.2012.01548.x","article-title":"Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue","volume":"9","author":"F Mar-Aguilar","year":"2012","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2010.07.021","article-title":"Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor","volume":"119","author":"F Wang","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:41:11Z","timestamp":1565253671000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090605"}},"subtitle":[],"editor":[{"given":"J\u00f6rg D.","family":"Hoheisel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090605","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]}}}